3-hydroxypregn-4-en-20-one has been researched along with bicuculline in 1 studies
Studies (3-hydroxypregn-4-en-20-one) | Trials (3-hydroxypregn-4-en-20-one) | Recent Studies (post-2010) (3-hydroxypregn-4-en-20-one) | Studies (bicuculline) | Trials (bicuculline) | Recent Studies (post-2010) (bicuculline) |
---|---|---|---|---|---|
29 | 0 | 2 | 6,253 | 3 | 759 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kavaliers, M; Wiebe, JP | 1 |
1 other study(ies) available for 3-hydroxypregn-4-en-20-one and bicuculline
Article | Year |
---|---|
Analgesic effects of the putative FSH-suppressing gonadal steroid, 3 alpha-hydroxy-4-pregnen-20-one: possible modes of action.
Topics: 20-alpha-Dihydroprogesterone; Analgesia; Analgesics; Animals; Bicuculline; Calcium Channel Blockers; Cerebral Ventricles; Flumazenil; Follicle Stimulating Hormone; Injections, Intraventricular; Male; Mice; Naloxone; Progesterone; Reference Values | 1988 |